EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease

Jacob Cleman, Juan G Sierra, Gaëlle Romain, Bella Capuano, Lindsey Scierka, Santiago Callegari, Francky Jacque, Poghni Peri-Okonny, Sameer Nagpal, Kim G Smolderen, Carlos Mena-Hurtado

Journal of Vascular Surgery · 2024

DOI: 10.1016/j.jvs.2024.04.016 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Jacob Cleman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Medicine Outcomes Program, Yale University, New Haven, CT. Hauptthemen laut MEDLINE: Amputation, Surgical, Renal Insufficiency, Chronic, Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCCIH NIH HHS, National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Comorbid chronic kidney disease (CKD) is associated with worse outcomes for patients with chronic limb-threatening ischemia (CLTI). However, comparative effectiveness data are limited for lower extremity bypass (LEB) vs peripheral vascular intervention (PVI) in patients with CLTI and CKD. We aimed to evaluate (1) 30-day all-cause mortality and amputation and (2) 5-year all-cause mortality and amputation for LEB vs PVI in patients with comorbid CKD. METHODS: Individuals who underwent LEB and PVI were queried from the Vascular Quality Initiative with Medicare claims-linked outcomes data. Propensity scores were calculated using 13 variables, and a 1:1 matching method was used. The mortality risk at 30 days and 5 years in LEB vs PVI by CKD was assessed using Kaplan-Meier and Cox proportional hazards models, with interaction terms added for CKD. For amputation, cumulative incidence functions and Fine-Gray models were used to account for the competing risk of death, with interaction terms for CKD added. RESULTS: Of 4084 patients (2042 per group), the mean age was 71.0 ± 10.8 years, and 69.0% were male. Irrespective of CKD status, 30-day mortality (hazard ratio [HR]: 0.94, 95% confidence interval [CI]: 0.63-1.42, P = .78) was similar for LEB vs PVI, but LEB was associated with a lower risk of 30-day amputation (sub-HR [sHR]: 0.66, 95% CI: 0.44-0.97, P = .04). CKD status, however, did not modify these results. Similarly, LEB vs PVI was associated with a lower risk of 5-year mortality (HR: 0.79, 95% CI: 0.71-0.88, P < .001) but no difference in 5-year amputation (sHR: 1.03, 95% CI: 0.89-1.20, P = .67). CKD status did not modify these results. CONCLUSIONS: Regardless of CKD status, patients had a lower risk of 5-year all-cause mortality and 30-day amputation with LEB vs PVI. Results may help inform preference-sensitive treatment decisions on LEB vs PVI for patients with CLTI and CKD, who may commonly be deemed too high risk for surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amputation, SurgicalRenal Insufficiency, ChronicPeripheral Arterial DiseaseChronic Limb-Threatening IschemiaComorbidityLimb SalvageHumansMaleFemaleAgedRisk FactorsTime FactorsRisk AssessmentUnited StatesAged, 80 and overRetrospective StudiesTreatment OutcomeMiddle AgedEndovascular ProceduresLower ExtremityVascular GraftingDatabases, FactualMedicareIschemiaVascular Surgical Procedures

Stichwörter der Autor:innen

BypassChronic limb-threatening ischemiaComparative effectivenessEndovascularPeripheral artery disease

Autor:innen und Institutionen

  • Vascular Medicine Outcomes Program, Yale University, New Haven, CT.
  • Department of Internal Medicine, Division of Cardiology, Naples Healthcare System, Naples Heart Institute, Naples, FL.
  • Vascular Medicine Outcomes Program, Yale University, New Haven, CT; Department of Internal Medicine, Division of Cardiology, Yale School of Medicine, New Haven, CT.
  • Vascular Medicine Outcomes Program, Yale University, New Haven, CT; Department of Psychiatry, Yale School of Medicine, New Haven, CT.
  • Vascular Medicine Outcomes Program, Yale University, New Haven, CT; Department of Internal Medicine, Division of Cardiology, Yale School of Medicine, New Haven, CT. Electronic address: carlos.menahurtado@yale.edu.

Förderung

  • NHLBI NIH HHS
  • NCCIH NIH HHS
  • National Heart Lung and Blood Institute

Zitieren

APA

Cleman, J., Sierra, J. G., Romain, G., Capuano, B., Scierka, L., Callegari, S., Jacque, F., Peri-Okonny, P., Nagpal, S., Smolderen, K. G., & Mena-Hurtado, C. (2024). Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2024.04.016

Vancouver

Cleman J, Sierra JG, Romain G, Capuano B, Scierka L, Callegari S, et al. Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2024.04.016

BibTeX
@article{Cleman2024,
  author = {Cleman, Jacob and Sierra, Juan G and Romain, Gaëlle and Capuano, Bella and Scierka, Lindsey and Callegari, Santiago and Jacque, Francky and Peri-Okonny, Poghni and Nagpal, Sameer and Smolderen, Kim G and Mena-Hurtado, Carlos},
  title = {Comparison of mortality and amputation after lower extremity bypass versus peripheral vascular intervention in patients with chronic limb-threatening ischemia and comorbid chronic kidney disease},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  doi = {10.1016/j.jvs.2024.04.016}
}
Kostenlos starten →